TO AMEND THE COVERAGE OF CONTINUOUS GLUCOSE MONITORS WITHIN THE ARKANSAS MEDICAID PROGRAM.

Senate Bill 576 (Act 623) amends the eligibility requirements for continuous glucose monitor (CGM) coverage under the Arkansas Medicaid program. This bill directly affects Arkansas Medicaid beneficiaries who have certain types of diabetes or glycogen storage disease type 1a. Under the amended law, CGMs will be covered for individuals with Type 1 diabetes or other forms of diabetes who use insulin more than twice daily, or who have evidence of Level 2 or Level 3 hypoglycemia. Coverage is also extended to those diagnosed with glycogen storage disease type 1a.